Last Updated on November 17, 2021 by The Health Master
Sun Pharma recently said that it is gearing up to introduce Merck Sharpe Dohme (MSD) and Ridgeback’s Molnupiravir under the brand name Molxvir in India.
The Drugs Controller General of India (DCGI) is currently reviewing clinical data of Molnupiravir for the treatment of C-19 in adults in India.
Earlier this year, the company had signed a non-exclusive voluntary licensing agreement with MSD to manufacture and supply Molnupiravir in India and to over 100 low- and middle-income countries (LMICs), Sun Pharma said in a statement.
It also said that Molnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for the treatment of mild-to-moderate C-19 in adults.
It is under review by the US Food and Drug Administration (USFDA) for Emergency Use Authorisation (EUA).
Kirti Ganorkar, CEO, India Business, Sun Pharma, said, “The recent authorisation of Molnupiravir licensed from MSD and Ridgeback by the UK regulator is a positive step.
In line with our consistent efforts to accelerate access to new drugs for C-19 treatment, we are gearing up to make Molxvir available to patients and healthcare providers across India at an economical price post-approval by DCGI.
Molxvir will be manufactured at one of our plants in India and we have enough capacity to meet the demand.”
According to the statement, in the phase-III trial by Merck, Molnupiravir significantly reduced the risk of hospitalisation or death by approximately 50 per cent in a planned interim analysis of the MOVe-OUT trial in at risk, non-hospitalised adult patients with mild-to-moderate C-19.
Additionally, based on the participants with available viral sequencing data (approximately 40 per cent of participants), Molnupiravir demonstrated consistent efficacy across viral variants like Gamma, Delta and Mu.
IPC adds new impurities and Reference Standards: Download the list
Special search operation at Medical Stores: FDA Punjab
Zydus Cadila’s vaccine to be administered to adults only as of now
In 10 minutes, a drone delivers 50 vaccination vials to PHC
Latest Circulars by ICMR on Pharmaceuticals
Drug alert: 36 out of 1061 samples declared as NSQ in October 2021
FAQs – on Medical Store / Pharmacy (Retail sale or Wholesale)
Latest Circulars by the Govt of India, Dept of Pharmaceuticals, Health…
Govt agrees with proposal to grant Jan Aushadhi license only to Registered Pharmacists
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
